Insulet (PODD) Income from Continuing Operations (2010 - 2026)

Insulet (PODD) reported Income from Continuing Operations of 91100000.0 for Q1 2026, up 156.62% on a YoY basis from 35500000.0 in Q1 2025, and down 10.42% quarter-over-quarter from 101700000.0 in Q4 2025.

Insulet (PODD) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Insulet has reported Income from Continuing Operations for 17 years, with the latest figure at 91100000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Income from Continuing Operations rose 156.62% year-over-year to 91100000.0; the trailing twelve-month figure through Mar 2026 stood at 302900000.0 (down 24.71% YoY), and the FY2025 full-year result was 247100000.0, down 40.93% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 91100000.0, down from 101700000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 188600000.0 in Q2 2024, with the low at 35000000.0 in Q2 2022.
  • Historically, Income from Continuing Operations has averaged 56923529.41 across 5 years, with a median of 51500000.0 in 2024.
  • Annual changes were most pronounced in 2022 — Income from Continuing Operations plunged 141.27% — and 2023, when it surged 1098.08%.
  • Insulet's Income from Continuing Operations stood at 17000000.0 in 2022, then jumped by 508.24% to 103400000.0 in 2023, then retreated by 2.61% to 100700000.0 in 2024, then advanced by 0.99% to 101700000.0 in 2025, then decreased by 10.42% to 91100000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 91100000.0 (Q1 2026), 101700000.0 (Q4 2025), and 87600000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.08 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 745.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 380.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 273.95 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 411.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 220.30 Mn
10 Insulet 10.20 Bn 9.72 Bn 529.10 Mn 91.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 91.10 Mn
Dec 31, 2025 101.70 Mn
Sep 30, 2025 87.60 Mn
Jun 30, 2025 22.50 Mn
Mar 31, 2025 35.50 Mn
Dec 31, 2024 100.70 Mn
Sep 30, 2024 77.50 Mn
Jun 30, 2024 188.60 Mn
Mar 31, 2024 51.50 Mn
Dec 31, 2023 103.40 Mn
Sep 30, 2023 51.90 Mn
Jun 30, 2023 27.30 Mn
Mar 31, 2023 23.80 Mn
Dec 31, 2022 17.00 Mn
Sep 30, 2022 -5.20 Mn
Jun 30, 2022 -35.00 Mn
Mar 31, 2022 27.80 Mn
Dec 31, 2021 29.20 Mn
Sep 30, 2021 12.60 Mn
Jun 30, 2021 -25.00 Mn